| Literature DB >> 30707099 |
Cheng-Yi Yang1, Ray-Jade Chen2,3, Wan-Lin Chou3, Yuarn-Jang Lee4, Yu-Sheng Lo1.
Abstract
BACKGROUND: Influenza is a leading cause of death worldwide and contributes to heavy economic losses to individuals and communities. Therefore, the early prediction of and interventions against influenza epidemics are crucial to reduce mortality and morbidity because of this disease. Similar to other countries, the Taiwan Centers for Disease Control and Prevention (TWCDC) has implemented influenza surveillance and reporting systems, which primarily rely on influenza-like illness (ILI) data reported by health care providers, for the early prediction of influenza epidemics. However, these surveillance and reporting systems show at least a 2-week delay in prediction, indicating the need for improvement.Entities:
Keywords: electronic disease surveillance; electronic health records; electronic medical records; epidemics; influenza; influenza surveillance; public health
Mesh:
Year: 2019 PMID: 30707099 PMCID: PMC6376337 DOI: 10.2196/12341
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Integrated Influenza Surveillance Framework for influenza epidemic surveillance. ILI: influenza-like illness; EMR: electronic medical record; TWCDC: Taiwan Centers for Disease Control and Prevention; TMUH: Taipei Medical University Hospital; WFH: Wan Fang Hospital; SHH: Shuang Ho Hospital.
Influenza surveillance variables and the corresponding data definitions.
| Surveillance variable (abbreviation) | Description | Definition |
| ILIa diagnosis codes [ | Patients who were diagnosed with ILI-related symptoms | ILI diagnosis codes: (1) ICD-9-CMc codes: 480.xx~487.xx.; (2) ICD-10-CM codesd: J09-~J18-, A22-, A37-, B25-, and B44- |
| Rapid influenza laboratory tests with positive results (TMUHcS-RITPe) | Patients who had positive results on rapid influenza tests based on ILI diagnosis codes | Rapid Influenza laboratory tests: positive, + And ILI diagnosis codes: (1) ICD-9-CM codes: 480.xx~487.xx (2) ICD-10-CM codesd: J09-~J18-, A22-, A37-, B25-, and B44- |
| Influenza medication use (TMUHcS-IMUf) | Patients who were prescribed with antiviral drugs against influenza based on ILI diagnosis codes | Medications: Tamiflu, Relenza, Rapiacta, and Avigan And ILI diagnosis codes: (1) ICD-9-CM codes: 480.xx-487.xx (2) ICD-10-CM codesd: J09- to J18-, A22-, A37-, B25-, and B44- |
aILI: influenza-like illness.
bTMUHcS: Taipei Medical University Health Care System.
cICD-9-CM: International Classification of Disease, Ninth Revision, Clinical Modification.
dImplemented in Taiwan in January 2016.
eRITP: rapid influenza laboratory tests with positive results.
fIMU: influenza medication use.
Figure 2Timeline of influenza-related case proportions based on national influenza-like illness (ILI) data, regional ILI data, and surveillance variables from the electronic medical records of Taipei Medical University Health Care System (TMUHcS; October 2014 to September 2017). IMU: influenza medication use; RITP: rapid influenza laboratory tests with positive results.
Pearson correlation coefficients between the Taiwan Center for Disease Control Regional influenza-like illness data and each surveillance variable from the electronic medical records of Taipei Medical University Health Care System (October 2014 to September 2017).
| Time period | National ILIa | TMUHcSb-ILI | TMUHcS-RITPc | TMUHcS-IMUd |
| Regional ILI of the entire period (October 2014 to September 2017) | .99 | .87 | .86 | .90 |
| Regional ILI of period 1 (October 2014 to September 2015) | .99 | .97 | .88 | .96 |
| Regional ILI of period 2 (October 2015 to September 2016) | .99 | .93 | .92 | .97 |
| Regional ILI of period 3 (October 2016 to September 2017) | .99 | .96 | .82 | .91 |
aILI: influenza-like illness.
bTMUHcS: Taipei Medical University Health Care System.
cRITP: rapid influenza laboratory tests with positive results.
dIMU: influenza medication use.
Pearson correlation coefficients between the Taiwan Center for Disease Control National influenza-like illness data and each surveillance variable from the electronic medical records of Taipei Medical University Health Care System (October 2014 to September 2017).
| Time period | Regional ILIa | TMUHcSb-ILI | TMUHcS-RITPc | TMUHcS-IMUd |
| National ILI of the entire period (October 2014 to September 2017) | .99 | .88 | .90 | .93 |
| National ILI of period 1 (October 2014 to September 2015) | .99 | .98 | .87 | .96 |
| National ILI of period 2 (October 2015 to September 2016) | .99 | .94 | .95 | .97 |
| National ILI of period 3 (October 2016 to September 2017) | .99 | .97 | .88 | .96 |
aILI: influenza-like illness.
bTMUHcS: Taipei Medical University Health Care System.
cRITP: rapid influenza laboratory tests with positive results.
dIMU: influenza medication use.
Figure 3Epidemic thresholds for each surveillance variable (October 2014 to September 2017; locally estimated scatterplot smoothing adjusted). TMUHcS: Taipei Medical University Health Care System; ILI: influenza-like illness; IMU: influenza medication use; RITP: rapid influenza laboratory tests with positive results.